Stay updated on Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial
Sign up to get notified when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.

Latest updates to the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page
- Check3 days agoChange DetectedThe page shows Revision: v3.3.4, replacing the prior Revision: v3.3.3.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page reorganizes location information under a new top-level 'Locations' section listing CA, FL, KS, MN, NE, NC, OH, and TX, removing the prior per-state subsections; the overall geographic coverage remains the same.SummaryDifference1%

- Check53 days agoChange DetectedAdded a new revision label 'Revision: v3.3.2'. Removed the previous revision label 'Revision: v3.2.0'.SummaryDifference0.1%

- Check60 days agoChange DetectedAn administrative notice about government funding and potential updates has been removed from the page. The core study details, eligibility criteria, and other essential information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedThe Study Details page for NCT02640729 shows no additions or deletions. The content and sections such as Study Overview, Eligibility Criteria, and Locations appear unchanged.SummaryDifference0.4%

- Check103 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference6%

Stay in the know with updates to Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nelotanserin for Visual Hallucinations in Lewy Body Dementia Clinical Trial page.